PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-10-04

Date Title Company
04-Oct-2019 Neurocrine Biosciences Presents New Data Analyses Demonstrating Long-Term Effects of INGREZZA® (valbenazine) 40 mg Once-Daily in Patients with Tardive Dyskinesia at the 2019 Annual Psych Congress Neurocrine Biosciences, Inc.
04-Oct-2019 Neurocrine Biosciences Presents New Data Analyses Demonstrating Long-Term Effects of INGREZZA® (valbenazine) 40 mg Once-Daily in Patients with Tardive Dyskinesia at the 2019 Annual Psych Congress Neurocrine Biosciences, Inc.
04-Oct-2019 Statement from Acting FDA Commissioner Ned Sharpless, M.D., on consumer warning to stop using THC vaping products amid ongoing investigation into lung illnesses U.S. Food and Drug Administration
04-Oct-2019 Statement from Acting FDA Commissioner Ned Sharpless, M.D., on consumer warning to stop using THC vaping products amid ongoing investigation into lung illnesses U.S. Food and Drug Administration
04-Oct-2019 Biophytis Opens 22nd Clinical Site in the SARA-INT Phase 2b Trial of Sarconeos (BIO101) for the Treatment of Sarcopenia Biophytis
04-Oct-2019 Innovative new VMAR product to be showcased at this year’s Pharmacy Show Omnicell
04-Oct-2019 New analysis of Fasenra Phase III GALATHEA and TERRANOVA COPD trials identifies factors associated with exacerbation rate reductions AstraZeneca
04-Oct-2019 Fasenra approved in the US for self-administration in a new pre-filled auto-injector, the Fasenra Pen AstraZeneca
04-Oct-2019 Q BioMed Announces Commercial Partnership with Jubilant Radiopharma for the Distribution of its Non-Opioid Cancer Palliation Drug in the United States Q BioMed Inc
04-Oct-2019 Univercells boosted by EUR 20m European financing to accelerate the delivery of its vaccine portfolio Univercells
04-Oct-2019 North America leads in number of strategic pharma partnerships between 2014 and H1 2019, says GlobalData GlobalData
04-Oct-2019 Expedeon AG: Expedeon AG announces conversion to registered shares (news with additional features) Expedeon AG
04-Oct-2019 HEOR Services Outsourced by 75 Percent of Top/Mid Pharma, Says Beroe Inc Beroe Inc.
04-Oct-2019 Sandoz welcomes English High Court decision refuting GSK claims re AirFluSal® Forspiro® inhaler Sandoz
04-Oct-2019 Montmed announces positive clinical trial data on SiteSmart(TM) Montméd
04-Oct-2019 Montmed announces positive clinical trial data on SiteSmart(TM) Montméd
04-Oct-2019 BellaSeno Presents Case Study on Regulatory Approval of Novel 3D-Printed Medical Devices Bella Seno GmbH
04-Oct-2019 EVOTEC REACHES MILESTONE IN INTEGRATED DRUG DISCOVERY AND DEVELOPMENT PARTNERSHIP WITH AEOVIAN Evotec SE
04-Oct-2019 Heron Therapeutics Announces Pricing of Public Offering of Common Stock Heron Therapeutics, Inc.